Foreman K E, Bacon P E, Hsi E D, Nickoloff B J
Skin Disease Research Laboratories, Loyola University Medical Center, Maywood, Illinois 60153-5385, USA.
J Clin Invest. 1997 Jun 15;99(12):2971-8. doi: 10.1172/JCI119492.
Several lines of investigation point to a new herpesvirus, human herpesvirus-8 (HHV-8), as the cause of two different neoplasms seen in AIDS patients-Kaposi's sarcoma (KS) and body cavity B cell lymphoma. If this virus is the etiological agent, rather than another opportunistic infectious agent, it should be present in the earliest detectable clinical lesions on a temporal basis, and localize to specific target cells in a spatial pattern consistent with tumorigenic pathways. In this study, we take advantage of the clinical accessibility to biopsy early (patch stage) skin lesions of KS to address the temporal issue, combined with in situ PCR and dual immunostaining using a marker identifying malignant cells, to address the spatial localization issue. 21 different tissue samples were subjected to PCR analysis and in situ PCR with and without simultaneous immunostaining. In normal skin from healthy individuals, no HHV-8 DNA was detected by PCR or in situ PCR. However, in all PCR-positive tissues, distinct and specific in situ PCR staining was observed. In four different patch stage KS lesions, in situ PCR staining localized to nuclei of endothelial cells and perivascular spindle-shaped tumor cells. Later stage KS lesions (plaques and nodules) revealed additional positive cells, including epidermal keratinocytes (four of five), and eccrine epithelia (two of four). These patterns were nonrestricted to skin, as pulmonary KS also revealed HHV-8-specific infection of endothelial cells and KS tumor cells, as well as epithelioid pneumocytes (two of two). In body cavity B cell lymphoma by dual staining, HHV-8 was present in malignant tumor cells (EMA immunostained positive) and not in reactive lymphocytes. These results reveal an early temporal onset and nonrandom tissue and cellular distribution pattern for HHV-8 infection that is consistent with a causal link between this DNA virus and two AIDS-related neoplasms.
多项研究线索表明,一种新的疱疹病毒——人类疱疹病毒8型(HHV - 8)是艾滋病患者中出现的两种不同肿瘤的病因,即卡波西肉瘤(KS)和体腔B细胞淋巴瘤。如果这种病毒是病原体,而非另一种机会性感染因子,那么从时间上来说,它应该存在于最早可检测到的临床病变中,并且在空间上定位于与致瘤途径一致的特定靶细胞。在本研究中,我们利用临床可获取的早期(斑片期)KS皮肤病变活检样本,来解决时间问题,并结合原位PCR以及使用识别恶性细胞的标记物进行双重免疫染色,以解决空间定位问题。对21个不同的组织样本进行了PCR分析、原位PCR,以及同时或不同时进行免疫染色。在健康个体的正常皮肤中,通过PCR或原位PCR均未检测到HHV - 8 DNA。然而,在所有PCR阳性组织中,均观察到了明显且特异的原位PCR染色。在四个不同的斑片期KS病变中,原位PCR染色定位于内皮细胞核和血管周围梭形肿瘤细胞。后期KS病变(斑块和结节)显示出更多阳性细胞,包括表皮角质形成细胞(5个中有4个)和汗腺上皮细胞(4个中有2个)。这些模式并非仅限于皮肤,因为肺部KS也显示出HHV - 8特异性感染内皮细胞、KS肿瘤细胞以及上皮样肺细胞(2个中有2个)。在体腔B细胞淋巴瘤中,通过双重染色发现,HHV - 8存在于恶性肿瘤细胞(EMA免疫染色阳性)中,而不存在于反应性淋巴细胞中。这些结果揭示了HHV - 8感染的早期时间发作以及非随机的组织和细胞分布模式,这与这种DNA病毒和两种艾滋病相关肿瘤之间的因果关系是一致的。